Organogenesis Holdings Inc. (ORGO) › Capital ExpendituresOrganogenesis Holdings Inc. (ORGO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $1.36M2017: $2.43M2018: $1.86M2019: $5.98M2020: $17.68M2021: $31.22M2022: $33.90M2023: $24.36M2024: $10.03M2025: $14.15M$14.15M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$14.15M+41.1%2024$10.03M-58.8%2023$24.36M-28.1%2022$33.90M+8.6%2021$31.22M+76.6%2020$17.68M+195.4%2019$5.98M+222.2%2018$1.86M-23.5%2017$2.43M+78.3%2016$1.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share